Sihuan Pharmaceutical Holdings Group Ltd. (FRA:TEL1)
Germany flag Germany · Delayed Price · Currency is EUR
0.1590
+0.0130 (8.90%)
At close: Nov 28, 2025

Sihuan Pharmaceutical Holdings Group Company Description

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People’s Republic of China and the United States.

It operates through three segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine.

The company offers filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care, and others, as well as non- or minimally invasive medical aesthetics comprehensive solutions.

It also provides drugs in the oncology, metabolism, diabetes, cardiovascular and cerebrovascular, modern Chinese medicine, and industrial hemp therapeutic areas.

In addition, the company involved in the provision of research and development, and industrialization of innovative medicine; construction for medical project; provision of general hospital services and hospital management services; and property investment business.

Sihuan Pharmaceutical Holdings Group Ltd. was founded in 2001 and is based in Wan Chai, Hong Kong.

Sihuan Pharmaceutical Holdings Group Ltd.
CountryBermuda
Founded2001
IndustryPharmaceutical Preparations
Employees2,667
CEOWeicheng Guo

Contact Details

Address:
Office Tower, Convention Plaza
Wan Chai
Hong Kong
Phone852 3628 3911
Websitesihuanpharm.com

Stock Details

Ticker SymbolTEL1
ExchangeFrankfurt Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyCNY
SIC Code2834

Key Executives

NamePosition
Weicheng GuoChief Executive Officer
Guili MiaoChief Financial Officer